By Matthew Guarnaccia ( August 24, 2018, 3:48 PM EDT) -- China Biologic Products Holdings Inc. on Friday rejected a $3.9 billion offer from a consortium that includes its former chief executive and several investment firms, while the biopharmaceutical company also said an affiliate of Chinese investment firm Citic Capital pulled back its own $3.65 billion proposal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.